# GreenLight Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/greenlight-biosciences

- Industry: Biotechnology
- Headquarters: Medford, US
- Website: www.greenlightbiosciences.com
- Total disclosed funding: $120M
- Latest round: Series D (Jun 15, 2020)
- Investors on record: 16

## About

Founded in 2008 and based in Massachusetts, US, GreenLight Biosciences, Inc. operates as a biotechnology company that focuses on developing and manufacturing for human, animal, and plant health. The firm was founded by Andrey Zarur and Marta Ortega-Valle, and has raised a total funding of USD 238.35 million in 2020. In August 2021, the firm entered into an agreement to merge with Environmental Impact Acquisition Corp., a special purpose acquisition company (SPAC) at the transaction value of USD 105 million. 

GreenLight Biosciences, Inc. provides a bioprocessing technology platform for developing mRNA vaccines and therapeutics for humans and RNA crop-protection products for food protection. The company's technology also enables the agricultural industry to biocontrol crops by repelling pests without harming the produce. Greenlight develops RNA-based pesticides which protect honeybees and staple food products from destructive insect pests. The company's platform enables the discovery, development, scaling, and delivery of RNA products and creates therapies, vaccines, and crop-protection products for human health and agriculture. 

GreenLight Biosciences combined with Environmental Impact Acquisition Corp. will become a publicly listed company on Nasdaq with an estimated enterprise value of USD 1.2 billion. The 2021 merger will advance the development of the biomanufacturing platform by hiring more employees, purchasing more tools, scaling up the manufacturing infrastructure, advancing regulatory approvals, and further developing the science.

## Funding rounds

- Series D, Jun 15, 2020, $103M — Baird Capital Partners, Continental Grain Company, Fall Line Capital, Cormorant Asset Management, S2G Ventures, Tao Capital Partners, Spruce Capital Partners, Lewis & Clark Ventures, AgFunder, Morningside, Lupa Systems
- Series D, Aug 31, 2017, $10M — Kodiak Venture Partners, Fall Line Capital, S2G Ventures, Spruce Capital Partners, Syngenta Ventures, Lewis & Clark Ventures, Marco Capital Group
- Series C, Jul 22, 2015 — Xeraya Capital, Spruce Capital Partners
- Series A, Jul 29, 2013, $7M — Kodiak Venture Partners, Khosla Ventures

## Investors

- Kodiak Venture Partners (https://capitalatlas.ai/funds/kodiak-venture-partners) — Series A, Series D
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A
- Xeraya Capital (https://capitalatlas.ai/funds/xeraya-capital) — Series C
- Spruce Capital Partners (https://capitalatlas.ai/funds/spruce-capital-partners) — Series C, Series D
- Fall Line Capital (https://capitalatlas.ai/funds/fall-line-capital) — Series D
- S2G Ventures (https://capitalatlas.ai/funds/s2g-ventures) — Series D
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series D
- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series D
- Marco Capital Group — Series D
- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series D
- Continental Grain Company (https://capitalatlas.ai/funds/continental-grain-company) — Series D
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series D
- Tao Capital Partners (https://capitalatlas.ai/funds/tao-capital-partners) — Series D
- AgFunder (https://capitalatlas.ai/funds/agfunder) — Series D
- Morningside (https://capitalatlas.ai/funds/morningside) — Series D
- Lupa Systems (https://capitalatlas.ai/funds/lupa-systems) — Series D